Table 2 Forward-selected Cox-regression identified increased T-status (T3/4) and lymph node positivity (N+) being associated with a 2.2 and 1.9-fold risk of disease associated deaths, while symptom duration did not impact survival. CI: confidence interval; HR: hazard ratio
p-value | HR | 95%-CI | |
|---|---|---|---|
Symptom duration | |||
<8 weeks vs. 8-12 weeks | 0.37 | 0.9 | 0.6-1.1 |
8-12 weeks vs. >12 weeks | 0.59 | 1.1 | 0.8-1.6 |
T1/2 vs. T3/4 | <0.0001 | 2.2 | 1.6-3.1 |
N0 vs. N+ | <0.0001 | 1.9 | 1.3-2.2 |